Summary:
We determined gut mucosal barrier injury (MBI) among 129 recipients of an allogeneic or autologous haematopoietic stem cell transplant (HSCT) who had been given different myeloablative regimens by measuring integrity using the lactulose/rhamnose (RHA) ratio and absorption using the ratios of rhamnose/3-O-methylglucose and xylose/3-O-methylglucose. Regimens that did not contain idarubicin induced oral mucositis and disturbed gut integrity and absorption earlier than did those containing the anthracycline. By contrast, regimens containing idarubicin induced more severe and prolonged oral and gut MBI. Gut integrity and absorption of most patients were still abnormal at discharge from hospital. These results confirm that the integrity and absorptive capacity of the gut is affected adversely by myeloablative regimens in general, although only two patterns of mucosal injury emerged depending on whether or not idarubicin was used.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parulekar W, Mackenzie R, Bjarnason G, Jordan RC . Scoring oral mucositis. Oral Oncol 1998; 34: 63–71.
Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue. Br J Haematol 2000; 110: 299.
Rapoport AP, Miller Watelet LF, Linder T et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999; 17: 2446–2453.
Blijlevens NMA, van't Land B, Donnelly JP et al. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 2004; 12: 227–233.
Schaap N, Schattenberg A, Bar B et al. Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 1997; 98: 750–759.
Muus P, Donnelly P, Schattenberg A et al. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent. Semin Oncol 1993; 20 (Suppl. 8): 47–52.
Donnelly JP, Muus P, Schattenberg A et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992; 9: 409–413.
Jansen G, Muskiet FAJ, Schierbeek H et al. Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivates, preceded by a simple and rapid prepurification method. Clin Chim Acta 1986; 157: 277–294.
Johnston JD, Harvey CJ, Menzies IS, Treacher DF . Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 1996; 24: 1144–1149.
Lim SG, Menzies IS, Lee CA et al. Intestinal permeability and function in patients infected with human immunodeficiency virus: a comparison with coeliac disease. Scand J Gastroenterol 1993; 28: 573–580.
Keefe DM, Cummins AG, Dale BM et al. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci Colch 1997; 92: 385–389.
Ijiri K, Potten CS . Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983; 47: 175–185.
Keefe DMK, Brealey J, Goland GJ, Cummins AG . Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632–637.
Cummins AG, Thompson FM, Butler RN et al. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin Sci 2001; 100: 379–386.
Verburg M, Renes IB, van Nispen DJPM et al. Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic damage and regeneration. J Histochem Cytochem 2002; 50: 1525–1536.
Beck PL, Wong JF, Li Y et al. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 2004; 126: 796–808.
Fegan C, Poynton CH, Whittaker JA . The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990; 5: 373–377.
Acknowledgements
We like to thank M Balvers and Bea van't Land for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blijlevens, N., Donnelly, J. & de Pauw, B. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 35, 707–711 (2005). https://doi.org/10.1038/sj.bmt.1704863
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704863
Keywords
This article is cited by
-
Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma
Supportive Care in Cancer (2023)
-
Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial
Trials (2020)
-
Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis
Cancer Chemotherapy and Pharmacology (2018)
-
Gastrointestinal Mucositis: The Role of MMP-Tight Junction Interactions in Tissue Injury
Pathology & Oncology Research (2014)
-
18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation
European Journal of Nuclear Medicine and Molecular Imaging (2012)